Study of the Efficacy of Topiramate in Patients With Prader Willi Syndrome Over 8 Weeks

NCT02810483 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

69

Enrollment

OTHER

Sponsor class

Conditions

Prader-Willi Syndrome

Interventions

DRUG: Topiramate
DRUG: Placebo Comparator

Sponsor

Assistance Publique - Hôpitaux de Paris